ARSK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.965600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.854600E-01
Normal-vs-Stage2
7.356000E-01
Normal-vs-Stage3
1.029620E-01
Normal-vs-Stage4
4.358400E-01
Stage1-vs-Stage2
3.719800E-02
Stage1-vs-Stage3
6.420000E-02
Stage1-vs-Stage4
7.628800E-01
Stage2-vs-Stage3
2.077400E-01
Stage2-vs-Stage4
2.060200E-01
Stage3-vs-Stage4
1.449580E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.331600E-01
Normal-vs-AfricanAmerican
9.851600E-01
Normal-vs-Asian
2.250400E-01
Caucasian-vs-AfricanAmerican
8.822000E-01
Caucasian-vs-Asian
8.827600E-02
AfricanAmerican-vs-Asian
1.885980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.714800E-01
Normal-vs-Female
9.418800E-01
Male-vs-Female
6.828000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.031400E-01
Normal-vs-Age(41-60Yrs)
7.420400E-01
Normal-vs-Age(61-80Yrs)
7.269800E-01
Normal-vs-Age(81-100Yrs)
5.136200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.718800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.275000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.481200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.684420E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.085000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.253600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.850800E-01
Normal-vs-Daily Drinker
3.285800E-01
Normal-vs-Weekly Drinker
8.236800E-01
Normal-vs-Occasional Drinker
8.302400E-01
Normal-vs-Social Drinker
8.792800E-01
Non Drinker-vs-Daily Drinker
7.971400E-01
Non Drinker-vs-Weekly Drinker
4.423600E-01
Non Drinker-vs-Occasional Drinker
9.403700E-02
Non Drinker-vs-Social Drinker
1.466210E-01
Daily Drinker-vs-Weekly Drinker
3.124800E-01
Daily Drinker-vs-Occasional Drinker
8.826300E-02
Daily Drinker-vs-Social Drinker
1.565630E-01
Weekly Drinker-vs-Occasional Drinker
4.681800E-01
Weekly Drinker-vs-Social Drinker
5.558000E-01
Occasional Drinker-vs-Social Drinker
9.265000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.295000E-01
Normal-vs-Grade 2
9.661800E-01
Normal-vs-Grade 3
8.930800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.812000E-01
Grade 1-vs-Grade 3
6.484800E-01
Grade 1-vs-Grade 4
8.295000E-01
Grade 2-vs-Grade 3
9.140600E-01
Grade 2-vs-Grade 4
9.661800E-01
Grade 3-vs-Grade 4
8.930800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.225000E-01
Normal-vs-NonDiabetic
9.038400E-01
Diabetic-vs-NonDiabetic
3.868600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.017200E-01
Normal-vs-NoPancreatitis
9.110600E-01
Pancreatitis-vs-NoPancreatitis
2.522600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.579400E-01
Normal-vs-N1
8.215200E-01
N0-vs-N1
7.010200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.865800E-01
Normal-vs-TP53-NonMutant
6.680400E-01
TP53-Mutant-vs-TP53-NonMutant
9.377600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
